%0 Journal Article
%T Safety and effectiveness of cannabinoids for the treatment of neuropsychiatric symptoms in dementia: a systematic review
%A Chris Alderman
%A Gillian E. Caughey
%A Jodie Belinda Hillen
%A Natalie Soulsby
%J Archive of "Therapeutic Advances in Drug Safety".
%D 2019
%R 10.1177/2042098619846993
%X Neuropsychiatric symptoms (NPS) in dementia impact profoundly on the quality of life of people living with dementia and their care givers. Evidence for the effectiveness and safety of current therapeutic options is varied. Cannabinoids have been proposed as an alternative therapy, mainly due to their activity on CB1 receptors in the central nervous system. However, little is known regarding the safety and effectiveness of cannabinoid therapy in people with dementia. A literature review was undertaken to identify, describe and critically appraise studies investigating cannabinoid use in treating NPS in dementia
%K Cannabinoids
%K Neuropsychiatric symptoms of dementia
%K dementia
%K review
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535742/